The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.

Trendowski, Matthew

The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells. [electronic resource] - Anticancer research May 2014 - 2195-202 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1791-7530


Antineoplastic Agents--pharmacology
Cytochalasin B--pharmacology
Humans
Leukemia--therapy
U937 Cells
Ultrasonic Therapy--methods